ODTX Insider Trading Activity and SEC Form 4 Filings
ODTX insider trading summary
Over the past 12 months, insiders at Odyssey Therapeutics, Inc. (ODTX) reported 14 open-market purchases worth $135.3M by 10 insiders and 6 sales worth $64K by 2 insiders on SEC Form 4. Net insider buying was $135.3M.
Latest ODTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 11, 2026 | Jon Winkelried | Insider | Buy | $25.0M (1,388,889 @ $18.00) |
| May 11, 2026 | Shelley Chu | Insider | Buy | $200K (11,111 @ $18.00) |
| May 11, 2026 | Nan (LN) Li | Insider | Buy | $20.0M (1,111,111 @ $18.00) |
| May 11, 2026 | Sr One Capital Management, LLC | Insider | Buy | $3.6M (200,000 @ $18.00) |
| May 11, 2026 | Tpg Gp A, LLC | Insider | Buy | $25.0M (1,388,889 @ $18.00) |
| May 11, 2026 | James G Coulter | Insider | Buy | $25.0M (1,388,889 @ $18.00) |
| May 11, 2026 | Sr One Capital Management, LLC | Insider | Sell | $19K (1,065 @ $18.00) |
| May 11, 2026 | Simeon George | Insider | Sell | $19K (1,065 @ $18.00) |
| May 11, 2026 | Sr One Capital Management, LLC | Insider | Buy | $4.0M (222,222 @ $18.00) |
| May 11, 2026 | Simeon George | Insider | Buy | $4.0M (222,222 @ $18.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.